A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

Clinical trial NCT04138277 · COMPLETED

Trial details

NCT number: NCT04138277
Sponsor: Amicus Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pompe Disease (Late-onset)

Start date: 2019-12-18
Primary completion: 2024-12-31
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.